NASDAQ:PRPO Precipio (PRPO) Stock Price, News & Analysis $19.17 -0.79 (-3.96%) Closing price 11/17/2026 04:00 PM EasternExtended Trading$19.19 +0.02 (+0.11%) As of 04:14 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOwnershipSEC Filings About Precipio Stock (NASDAQ:PRPO) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Precipio alerts:Sign Up Key Stats Today's Range$18.45▼$21.1950-Day Range$17.79▼$27.3252-Week Range$17.79▼$33.63Volume46,287 shsAverage Volume26,838 shsMarket Capitalization$34.31 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Precipio is a diagnostics company focused on hematologic cancers and other complex diseases. It provides specialized pathology and laboratory testing services to help physicians identify and characterize blood disorders and malignancies. The company also develops and sells diagnostic products for use by clinical laboratories. Its HemeScreen platform offers molecular testing for genetic mutations associated with blood cancers, while its broader product offerings support laboratories seeking to perform specialized diagnostic tests. Precipio operates a clinical laboratory in New Haven, Connecticut, and serves healthcare providers and laboratories through its testing services and diagnostic products. Its business combines direct laboratory services with products designed for use by other testing facilities.AI Generated. May Contain Errors. Read More Precipio Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks13th Percentile Overall ScorePRPO MarketRank™: 0.66493263972 of 5 starsPrecipio scored higher than 13% of companies evaluated by MarketBeat, and ranked 822nd out of 859 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingPrecipio has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoveragePrecipio has only been the subject of 1 research reports in the past 90 days.Read more about Precipio's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Precipio is -32.49, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Precipio is -32.49, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioPrecipio has a P/B Ratio of 2.31. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted3.68% of the float of Precipio has been sold short.Short Interest Ratio / Days to CoverPrecipio has a short interest ratio ("days to cover") of 1.47, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Precipio has recently decreased by 6.73%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldPrecipio does not currently pay a dividend.Dividend GrowthPrecipio does not have a long track record of dividend growth. News and Social Media2.2 / 5News Sentiment0.53 News SentimentPrecipio has a news sentiment score of 0.53. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Precipio this week, compared to 1 article on an average week. Company Ownership0.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Precipio insiders have not sold or bought any company stock.Percentage Held by Insiders16.60% of the stock of Precipio is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions10.45% of the stock of Precipio is held by institutions.Read more about Precipio's insider trading history. Receive PRPO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Precipio and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PRPO Stock News HeadlinesPrecipio Announces Q3-2026 Financial ResultsNovember 11, 2026 | insidermonkey.comPrecipio (PRPO) Q3 2026 Earnings Call TranscriptNovember 11, 2026 | finance.yahoo.comWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and the shift is already underway. The dollar has lost 88% of its purchasing power since it was untethered from gold, and Fortune calls the current change the biggest shift in the world's relationship with the dollar in a generation. Stansberry says a similar reset is planned to be unveiled in Miami as soon as this December. Watch Porter Stansberry's full broadcast to see which companies could be affected.November 18 at 1:00 AM | Porter & Company (Ad)Precipio Announces Q3-2026 Financial ResultsNovember 10, 2026 | globenewswire.comPrecipio Announces Q3 2026 Shareholder Update CallOctober 29, 2026 | tipranks.comPrecipio Announces Q3-2026 Shareholder Update CallOctober 29, 2026 | insidermonkey.comPrecipio Announces Q3-2026 Shareholder Update CallOctober 28, 2026 | globenewswire.comPrecipio: Management Dreams Big, Institutions Have A Toe InOctober 12, 2026 | seekingalpha.comSee More Headlines PRPO Stock Analysis - Frequently Asked Questions How have PRPO shares performed this year? Precipio's stock was trading at $22.98 at the beginning of 2026. Since then, PRPO shares have decreased by 16.6% and is now trading at $19.17. How were Precipio's earnings last quarter? Precipio, Inc. (NASDAQ:PRPO) posted its earnings results on Friday, August, 14th. The biotechnology company reported ($0.12) earnings per share (EPS) for the quarter, beating the consensus estimate of ($2.00) by $1.88. The biotechnology company had revenue of $7.02 million for the quarter, compared to analyst estimates of $1.68 million. Precipio had a negative net margin of 4.12% and a negative trailing twelve-month return on equity of 7.84%. Read the conference call transcript. When did Precipio's stock split? Precipio's stock reverse split before market open on Friday, September 22nd 2023.The 1-20 reverse split was announced on Friday, September 22nd 2023. The number of shares owned by shareholders was adjusted after the closing bell on Friday, September 22nd 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. How do I buy shares of Precipio? Shares of PRPO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Precipio own? Based on aggregate information from My MarketBeat watchlists, some other companies that Precipio investors own include Jaguar Animal Health (JAGX), iBio (IBIO), FuelCell Energy (FCEL), Gevo (GEVO), VBI Vaccines (VBIV), Sorrento Therapeutics (SRNE) and ADMA Biologics (ADMA). Company Calendar Last Earnings8/14/2026Today11/18/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (2d) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 As of 2 days ago, PRPO's financial health entered the Yellow zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryHealthcare Services Current SymbolNASDAQ:PRPO CIK1043961 Webwww.precipiodx.com Phone(203) 787-7888Fax402-452-5401Employees71Year FoundedN/AProfitability EPS (Trailing Twelve Months)($0.59) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$360 thousand Net Margins-4.12% Pretax Margin-4.12% Return on Equity-7.84% Return on Assets-5.37% Debt Debt-to-Equity Ratio0.06 Current Ratio1.77 Quick Ratio1.54 Sales & Book Value Annual Sales$24.05 million Price / Sales1.43 Cash Flow$0.76 per share Price / Cash Flow25.12 Book Value$8.29 per share Price / Book2.31Miscellaneous Outstanding Shares1,790,000Free Float1,495,000Market Cap$34.31 million OptionableNo Data Beta1.45 The 7 Best High-Yield Dividend Stocks for 2027Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.Get This Free Report This page (NASDAQ:PRPO) was last updated on 11/17/2026 by MarketBeat.com Staff. From Our PartnersYour $7 scanner is waitingThe Instant Scanner is $7 in Bill Poulos's Black Friday sale. Every night it delivers a list showing which sto...Profits Run | SponsoredPentagon magnet restrictions take effect January 1, 2027A NASDAQ-listed company has signed a term sheet outlining a potential 75-year agreement with the U.S. Army. It...OilPrice | SponsoredWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | SponsoredYour Social Security check is scheduled for a 22% cutThe U.S. now borrows money just to pay interest on money it already borrowed, a pattern economists call a debt...American Alternative | SponsoredBeyond NVDA: The World’s Next #1 Company?This small-cap trades in an overlooked corner of the market, with a market cap more than 600X smaller than Nvi...Banyan Hill Publishing | SponsoredYour father's savings lost half their value after 1971.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Precipio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Precipio With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.